Skip to content

Faculty profile

Michel Grandbois

Back to faculty
ResearcherPharmacologie-PhysiologieUniversité de Sherbrooke

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Sherbrooke directory, so their courses may be missing. Find their university profile.

Latest papers

  • Structure-Guided Design of Proteomimetics Targeting the SARS-CoV-2 S-RBD/hACE2 Interface.

    Journal of medicinal chemistry · 2026

  • A neurotensin receptor type 1-derived pepducin acts as a biased allosteric modulator to regulate target receptor function.

    Acta pharmaceutica Sinica. B · 2026

  • A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitor.

    Pharmacological research · 2025

All 48 publications

Latest funding

  • Biomechanical Optimization of 3D Muscle Stem Cell Culture in Elastic Substrates

    NSERC · 2025 · Co-investigator

    $150,000
  • Macrocyclic Inhibitors of the SARS-CoV-2 / ACE-2 Interaction in COVID-19

    NSERC · 2020 · Principal investigator

    $50,000
  • Peptide Diversity Generation Apparatus to Elucidate Cell-Molecules Interactions

    NSERC · 2019 · Co-investigator

    $149,980
All 14 grants and awards
Something wrong or missing on this profile? Suggest a correction